Codexis, Inc. (0I0X.L)

USD 2.59

(11.38%)

Total Assets Summary of Codexis, Inc.

  • Codexis, Inc.'s latest annual total assets in 2023 was 136.56 Million USD , down -45.46% from previous year.
  • Codexis, Inc.'s latest quarterly total assets in 2024 Q2 was 132 Million USD , down -11.74% from previous quarter.
  • Codexis, Inc. reported annual total assets of 250.39 Million USD in 2022, up 1.63% from previous year.
  • Codexis, Inc. reported annual total assets of 246.38 Million USD in 2021, up 11.16% from previous year.
  • Codexis, Inc. reported quarterly total assets of 149.55 Million USD for 2024 Q1, up 9.52% from previous quarter.
  • Codexis, Inc. reported quarterly total assets of 132 Million USD for 2024 Q2, down -11.74% from previous quarter.

Annual Total Assets Chart of Codexis, Inc. (2023 - 2006)

Historical Annual Total Assets of Codexis, Inc. (2023 - 2006)

Year Total Assets Total Assets Growth
2023 136.56 Million USD -45.46%
2022 250.39 Million USD 1.63%
2021 246.38 Million USD 11.16%
2020 221.64 Million USD 48.68%
2019 149.07 Million USD 90.43%
2018 78.28 Million USD 45.98%
2017 53.62 Million USD 50.43%
2016 35.64 Million USD -20.16%
2015 44.64 Million USD -7.22%
2014 48.12 Million USD -18.22%
2013 58.84 Million USD -41.14%
2012 99.96 Million USD -26.45%
2011 135.92 Million USD -3.81%
2010 141.3 Million USD 42.68%
2009 99.03 Million USD 39.72%
2008 70.88 Million USD -37.57%
2007 113.54 Million USD 143.34%
2006 46.65 Million USD 0.0%

Peer Total Assets Comparison of Codexis, Inc.

Name Total Assets Total Assets Difference
Xeris Biopharma Holdings, Inc. 340.79 Million USD 59.929%
Arrowhead Pharmaceuticals, Inc. 765.55 Million USD 82.162%
Viridian Therapeutics, Inc. 490.42 Million USD 72.155%
Organovo Holdings, Inc. 6.34 Million USD -2050.906%